2012
DOI: 10.1099/jmm.0.049007-0
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of two multiplex real-time PCR screening capabilities for the detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis in blood samples generated from murine infection models

Abstract: Two multiplex PCR screening capabilities (TaqMan Array Cards and FilmArray) were evaluated for their ability to detect Bacillus anthracis, Francisella tularensis and Yersinia pestis in blood samples obtained from respective murine infection models. Blood samples were obtained from infected mice at 24 h intervals after exposure. Multiplex PCR results were compared with standard blood culture and singleplex real-time PCR. Across all three models, 71 mice were tested in total, within which a subset of 43 samples … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
36
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
4

Relationship

2
8

Authors

Journals

citations
Cited by 37 publications
(36 citation statements)
references
References 17 publications
0
36
0
Order By: Relevance
“…One hundred femtograms of B. anthracis Ames strain DNA corresponds to 17.5 genome equivalents (3), and in a 20-l PCR mixture, 2.5% equates to a volume of 0.5 l. Extrapolating upward, 20 GEs in a 0.5-l volume would equate to a detectable agent concentration of 3.5 ϫ 10 4 CFU·ml Ϫ1 (17.5 ϫ 2,000) in whole blood. Although this is an improvement over the 10 6 -CFU·ml Ϫ1 level observed in a previous inhibitor resistance study with a Francisella tularensis PCR (17), an alternate study has demonstrated a pointof-care (PoC) PCR system, with integrated sample processing and DNA extraction, that is able to detect B. anthracis at sensitivities of 10 3 CFU·ml Ϫ1 and below in whole blood (29). Similarly, sample processing evaluations using the same PCR assays as those used here showed a relative sensitivity of 5 ϫ 10 1 CFU·ml Ϫ1 in whole blood when the nucleic acid was extracted (13).…”
Section: Discussionmentioning
confidence: 93%
“…One hundred femtograms of B. anthracis Ames strain DNA corresponds to 17.5 genome equivalents (3), and in a 20-l PCR mixture, 2.5% equates to a volume of 0.5 l. Extrapolating upward, 20 GEs in a 0.5-l volume would equate to a detectable agent concentration of 3.5 ϫ 10 4 CFU·ml Ϫ1 (17.5 ϫ 2,000) in whole blood. Although this is an improvement over the 10 6 -CFU·ml Ϫ1 level observed in a previous inhibitor resistance study with a Francisella tularensis PCR (17), an alternate study has demonstrated a pointof-care (PoC) PCR system, with integrated sample processing and DNA extraction, that is able to detect B. anthracis at sensitivities of 10 3 CFU·ml Ϫ1 and below in whole blood (29). Similarly, sample processing evaluations using the same PCR assays as those used here showed a relative sensitivity of 5 ϫ 10 1 CFU·ml Ϫ1 in whole blood when the nucleic acid was extracted (13).…”
Section: Discussionmentioning
confidence: 93%
“…TACs offer increased real-time PCR throughput (384 individual reactions) in a rapid, reproducible, and simple setup containing prespotted primer-and-probe combinations. This format has since been customized for larger field evaluations and for the detection of nonrespiratory syndromes (420)(421)(422)(423)(424). Mass spectrometry (MS) is a mature yet still evolving technology adapted to the rapid identification and classification of clinically relevant pathogens (for a review, see reference 425).…”
Section: Emerging Methods and Technologiesmentioning
confidence: 99%
“…Since this is an open platform, the user has control over the number of targets and the specific properties of the probes being used. The technology can also be used in a strip format for the simultaneous processing of up to 96 arrays, potentially allowing the development of higher throughput screening capabilities than other multiplex PCR-based platforms [23]. …”
Section: Discussionmentioning
confidence: 99%